Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-04-001851
Filing Date
2004-08-18
Accepted
2004-08-18 11:12:15
Documents
1
Period of Report
2004-08-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3044
  Complete submission text file 0001019687-04-001851.txt   4847
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
BUCALO LOUIS R MD (Reporting) CIK: 0001180760 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 04983350